Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Lung clearance index in subjects with cystic fibrosis in Italy.

Lombardi E, Gambazza S, Pradal U, Braggion C.

Ital J Pediatr. 2019 May 2;45(1):56. doi: 10.1186/s13052-019-0647-5. Review.

2.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
3.

The Advantages of Adding Hyaluronic Acid or Mannitol to Hypertonic Saline Inhalation Treatment in Cystic Fibrosis.

Cazzarolli C, Tartali C, Pradal U.

J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):141-142. doi: 10.1089/jamp.2016.1318. Epub 2016 Aug 26. No abstract available.

PMID:
27563742
4.

Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia.

Pifferi M, Bush A, Di Cicco M, Pradal U, Ragazzo V, Macchia P, Boner AL.

Eur Respir J. 2010 Apr;35(4):787-94. doi: 10.1183/09031936.00051509. Epub 2009 Sep 24.

5.

Nasal nitric oxide for early diagnosis of familial primary ciliary dyskinesia.

Bodini A, Rugolotto S, Pradal U, Zanotto G, Peroni D.

Arch Dis Child. 2008 May;93(5):452-3. doi: 10.1136/adc.2008.138636. No abstract available.

PMID:
18426950
6.

Nasal nitric oxide for early diagnosis of primary ciliary dyskinesia: practical issues in children.

Piacentini GL, Bodini A, Peroni D, Rigotti E, Pigozzi R, Pradal U, Boner AL.

Respir Med. 2008 Apr;102(4):541-7. doi: 10.1016/j.rmed.2007.11.013. Epub 2008 Jan 9.

7.

TG15 T5 allele in clinically discordant monozygotic twins with cystic fibrosis.

Picci L, Cameran M, Scarpa M, Pradal U, Melotti P, Assael BM, Castellani C.

Am J Med Genet A. 2007 Aug 15;143A(16):1936-7. No abstract available.

PMID:
17632788
8.

Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation.

Zariwala MA, Leigh MW, Ceppa F, Kennedy MP, Noone PG, Carson JL, Hazucha MJ, Lori A, Horvath J, Olbrich H, Loges NT, Bridoux AM, Pennarun G, Duriez B, Escudier E, Mitchison HM, Chodhari R, Chung EM, Morgan LC, de Iongh RU, Rutland J, Pradal U, Omran H, Amselem S, Knowles MR.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):858-66. Epub 2006 Jul 20.

9.

The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis.

Nicolis E, Pasetto M, Cigana C, Pradal U, Assael BM, Melotti P.

BMC Med Genet. 2006 Feb 7;7:7.

10.

Long-term azithromycin in cystic fibrosis: another possible mechanism of action?

Pradal U, Delmarco A, Morganti M, Cipolli M, Mini E, Cazzola G.

J Chemother. 2005 Aug;17(4):393-400.

PMID:
16167518
11.

Cystic fibrosis patients, infertile men, and their noses.

Pradal U, Piacentini GL.

Am J Respir Crit Care Med. 2004 Jan 15;169(2):141-2. No abstract available.

PMID:
14718229
12.

Clinicopathologic reports, case reports, and small case series: usher syndrome type 1 associated with primary ciliary aplasia.

Tosi GM, de Santi MM, Pradal U, Braggion C, Luzi P.

Arch Ophthalmol. 2003 Mar;121(3):407-8. No abstract available.

PMID:
12617715
13.

Early bronchopulmonary involvement in Crohn disease: a case report.

Valletta E, Bertini M, Sette L, Braggion C, Pradal U, Zannoni M.

BMC Gastroenterol. 2001;1:13. Epub 2001 Nov 6.

14.

Evidence of mild respiratory disease in men with congenital absence of the vas deferens.

Castellani C, Bonizzato A, Pradal U, Filicori M, Foresta C, La Sala GB, Mastella G.

Respir Med. 1999 Dec;93(12):869-75.

15.

Nasal potential difference in congenital bilateral absence of the vas deferens.

Pradal U, Castellani C, Delmarco A, Mastella G.

Am J Respir Crit Care Med. 1998 Sep;158(3):896-901.

PMID:
9731023
16.

Detection of tidal expiratory flow limitation in infants with cystic fibrosis: a pilot study.

Braggion C, Polese G, Fenzi V, Carli MV, Pradal U, Milic-Emili J.

Pediatr Pulmonol. 1998 Mar;25(3):213-5. No abstract available.

PMID:
9556014
17.

Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.

Delmarco A, Pradal U, Cabrini G, Bonizzato A, Mastella G.

Eur Respir J. 1997 May;10(5):1145-9.

18.

Effect of different inspiratory maneuvers on FEV1 in patients with cystic fibrosis.

Braggion C, Pradal U, Mastella G, Coates AL, Milic-Emili J.

Chest. 1996 Sep;110(3):642-7.

PMID:
8797405
19.

Determinants of maximal transdiaphragmatic pressure in adults with cystic fibrosis.

Pradal U, Polese G, Braggion C, Poggi R, Zanolla L, Mastella G, Rossi A.

Am J Respir Crit Care Med. 1994 Jul;150(1):167-73.

PMID:
8025744
20.

Hemoglobin desaturation during sleep and daytime in patients with cystic fibrosis and severe airway obstruction.

Braggion C, Pradal U, Mastella G.

Acta Paediatr. 1992 Dec;81(12):1002-6.

PMID:
1290842
21.

[Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].

Magni A, Pradal U, Cazzola G, Mastella G.

Pediatr Med Chir. 1990 Sep-Oct;12(5):531-4. Italian.

PMID:
2087426
22.

Transcutaneous blood gas analysis during sleep and exercise in cystic fibrosis.

Pradal U, Braggion C, Mastella G.

Pediatr Pulmonol. 1990;8(3):162-7.

PMID:
2349008

Supplemental Content

Loading ...
Support Center